We are live on
!
Find out more
FA
FMA Advisory Portfolio holdings
AUM
$268M
1-Year Est. Return
30.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+30.8%
3 Year Est. Return
+46.7%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$5.1M
(+2.3%)
Cap. Flow
+$3.24M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
25.41%
Holding
149
New
7
Increased
81
Reduced
56
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.72M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$790K |
| 3 |
First Trust Value Line Dividend Fund
FVD
|
+$693K |
| 4 |
Cedar Fair
FUN
|
+$299K |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$261K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.15M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$305K |
| 3 |
Emerson Electric
EMR
|
+$223K |
| 4 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$156K |
| 5 |
Citigroup
C
|
+$133K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.44% |
| 2 | Healthcare | 7.57% |
| 3 | Industrials | 7.38% |
| 4 | Consumer Staples | 7.11% |
| 5 | Technology | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
FNB Corp
FNB
$6.78B
| $12.8M | 5.56% |
1,110,122
+86
| +0% | +$972 |
|
2
Invesco QQQ Trust
QQQ
$455B
| $7.08M | 3.07% |
37,499
-27
| -0.1% | -$5.12K |
|
3
PepsiCo
PEP
$186B
| $5.6M | 2.43% |
40,866
+668
| +2% | +$88.7K |
|
|
MMP
4
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.17M | 2.24% |
78,024
+402
| +0.5% | +$26.5K |
|
5
American Electric Power
AEP
$73.7B
| $4.95M | 2.15% |
52,789
+178
| +0.3% | +$16.2K |
|
6
NextEra Energy
NEE
$187B
| $4.87M | 2.11% |
83,516
+1,388
| +2% | +$75.1K |
|
7
Mastercard
MA
$477B
| $4.61M | 2% |
16,961
-75
| -0.4% | -$20.7K |
|
8
Verizon
VZ
$194B
| $4.54M | 1.97% |
75,258
+2,939
| +4% | +$169K |
|
9
Visa
V
$677B
| $4.47M | 1.94% |
26,010
-106
| -0.4% | -$18.9K |
|
10
Chevron
CVX
$388B
| $4.45M | 1.93% |
37,554
+1,732
| +5% | +$210K |
|
11
Thermo Fisher Scientific
TMO
$211B
| $4.44M | 1.93% |
15,255
+6
| +0% | +$1.72K |
|
|
12
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $4.34M | 1.88% |
105,554
-7,469
| -7% | -$305K |
|
13
Walt Disney
DIS
$165B
| $4M | 1.74% |
30,723
+1,087
| +4% | +$150K |
|
14
JPMorgan Chase
JPM
$939B
| $3.85M | 1.67% |
32,744
-415
| -1% | -$46.9K |
|
15
AT&T
T
$165B
| $3.7M | 1.6% |
129,365
+9,502
| +8% | +$252K |
|
16
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
| $3.56M | 1.54% |
27,893
-813
| -3% | -$102K |
|
17
Kimberly-Clark
KMB
$36.4B
| $3.53M | 1.53% |
24,859
+83
| +0.3% | +$11.4K |
|
18
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.85B
| $3.5M | 1.52% |
43,748
+196
| +0.5% | +$15.4K |
|
19
Honeywell
HON
$77.1B
| $3.38M | 1.47% |
21,203
-77
| -0.4% | -$12.2K |
|
|
20
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
| $3.27M | 1.42% |
57,185
-2,706
| -5% | -$156K |
|
21
Bank of America
BAC
$435B
| $3.21M | 1.39% |
110,111
-3,837
| -3% | -$110K |
|
22
Vanguard High Dividend Yield ETF
VYM
$81.1B
| $2.85M | 1.24% |
32,143
+179
| +0.6% | +$15.7K |
|
|
23
CVS Health
CVS
$137B
| $2.75M | 1.2% |
43,679
+29,019
| +198% | +$1.72M |
|
24
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $2.72M | 1.18% |
67,534
-614
| -0.9% | -$24.6K |
|
25
Lamar Advertising Co
LAMR
$16.2B
| $2.67M | 1.16% |
32,636
+680
| +2% | +$53.7K |
|
Similar funds
DMK
HCIA
ISG
KCP
MCL
TPCM
DCM
SMR
FMA Advisory's Q3 2019 Portfolio in Review
As of Q3 2019, FMA Advisory held 149 positions worth $230M, up 2.3% from $225M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
FMA Advisory's Q3 2019 filing shows 7 new, 81 increased, 56 reduced and 1 closed positions. Its largest new stake was Bristol-Myers Squibb: 16,808 shares worth $852K. The largest sale was Johnson & Johnson, an estimated $1.15M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.
- FMA Advisory's largest Q3 2019 buy was Bristol-Myers Squibb: 16,808 shares worth $852K.
- FMA Advisory added most to CVS Health in Q3 2019, an estimated $1.72M increase.
- FMA Advisory's biggest Q3 2019 reduction was Johnson & Johnson, cutting an estimated $1.15M.
- FMA Advisory fully exited Nokia in Q3 2019, selling an estimated $67K.
- FMA Advisory's ten largest holdings make up 25% of its $230M portfolio in Q3 2019.
- FMA Advisory opened 7 new positions and closed 1 in Q3 2019.
- FMA Advisory's portfolio value rose 2.3% quarter-over-quarter to $230M.
Based on FMA Advisory's 13F filing for Q3 2019, filed 12 Apr 2021.